MATTHEWS, N.C.--(BUSINESS WIRE)--CEM Corporation, a leading global provider of microwave laboratory instrumentation, is pleased to announce that its patent claims for the microwave peptide synthesis process have now been allowed in Europe by the European Patent Office. The allowed application contains broad claims regarding the process of using microwave energy to accelerate two key steps in performing almost all solid phase peptide synthesis, deprotection and coupling. It also covers the process of performing Fmoc and Boc chemistries, the two most common strategies employed in peptide synthesis.
